Skip to Content


In the US, Acitretin (acitretin systemic) is a member of the drug class antipsoriatics and is used to treat Pityriasis rubra pilaris, Psoriasis and Psoriatic Arthritis.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories



Chemical Name

(all-E)-9-(4-metoxy-2,3,6-trimetylphenyl)-3,7-dimetyl-2,4,6,8-nonatetraenoic acid (WHO)

Foreign Names

  • Acitretinum (Latin)
  • Acitretin (German)
  • Acitrétine (French)
  • Acitretina (Spanish)

Generic Names

  • Acitretin (OS: BAN, USAN)
  • Acitrétine (OS: DCF)
  • Etretin (IS)
  • Ro 10-1670 (IS: Roche)
  • Acitretin (PH: BP 2016, Ph. Eur. 8, USP 38)
  • Acitrétine (PH: Ph. Eur. 8)
  • Acitretinum (PH: Ph. Eur. 8)

Brand Names

  • Aceret
    Glenmark, India
  • Acetec
    Dr. Reddy's, India
  • Acicutan
    Dermapharm, Switzerland; Dermapharm, Germany
  • Acitren
    Sun-Farm, Poland
  • Acitretin
    Genus Pharmaceuticals, United Kingdom; Sabaa, Egypt
  • Acitretina IFC
    Cantabria, Spain
  • Acitretine CF
    Centrafarm, Netherlands
  • Acitretine IFC
    Industrial, Netherlands
  • Acitrexol
    AC Farma, Peru
  • Fang Xi
    Huabang Medical & Chemical, China
  • Keracutan
    Pelpharma, Austria
  • Keraderm
    Dermapharm, Netherlands
  • Neotigason
    Actavis, Australia; Actavis, Belgium; Actavis, Switzerland; Actavis, Czech Republic; Actavis, Germany; Actavis, Denmark; Actavis, Algeria; Actavis, Spain; Actavis, Greece; Actavis, Hong Kong; Actavis, Hungary; Actavis, Israel; Actavis, Iraq; Actavis, Latvia; Actavis, Malta; Actavis, Nigeria; Actavis, Netherlands; Actavis, Norway; Actavis, New Zealand; Actavis, Romania; Actavis, Sudan; Actavis, Sweden; Actavis, Singapore; Actavis, Slovakia; Actavis, Turkey; Actavis, Venezuela; Actavis Baltics Eesti, Estonia; Actavis Group, Austria; Actavis Group, Iceland; Actavis Group, Poland; Actavis Group, Russian Federation; Actavis Italy, Italy; Actavis UK, United Kingdom; Agmar, Croatia (Hrvatska); Allergan, Thailand; Aurobindo, Netherlands; Aurovitas, Portugal; Cenexi, Bulgaria; Cenexi SAS, Serbia; Euro Registratie, Netherlands; Fisher Farma, Netherlands; Pascual, Philippines; Patheon, Taiwan; Quideca, Colombia; Roche, Brazil; Roche, China; Roche, Ecuador; Roche, Lithuania; Roche, Peru; Roche, Tunisia; Roche, South Africa; Sandoz, Argentina
  • Neotigazone
    Patheon, Oman
  • Novatretin
    Douglas, New Zealand
  • Regioderm
    Regiomedica, Netherlands
  • Soriatane
    Arrow, France; GlaxoSmithKline, United States; Tribute, Canada
  • Unitrin
    Uni Pharma, Egypt
  • Zorias
    Difa Cooper, Italy


BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.